Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines. [electronic resource]
- Rheumatology (Oxford, England) Mar 2003
- 490 p. digital
Publication Type: Letter
1462-0324
10.1093/rheumatology/keg113 doi
Antibodies, Monoclonal--therapeutic use Antirheumatic Agents--therapeutic use Humans Practice Guidelines as Topic Spondylitis, Ankylosing--drug therapy Tumor Necrosis Factor-alpha--antagonists & inhibitors